FIELD: male contraception.
SUBSTANCE: following is provided: a method of non-hormonal contraception for a male subject, comprising administering a composition once daily, the said composition being a sustained release formulation containing: (R)-silodosin as an alpha-1 adrenoceptor antagonist and at least one pharmaceutically acceptable carrier. The composition is administered at approximately the same time in an effective amount that induces prolonged reversible aspermia, azoospermia or severe oligozoospermia in a male subject, and after an initial period of at least two consecutive days, a delay in taking a subsequent single daily dose does not affect the contraceptive effect.
EFFECT: side effects when using the method are largely limited, the method of administration of the composition is simple, the action is reversible, if there is a delay in the recommended regimen, such a delay does not diminish the effectiveness of contraception.
11 cl, 5 tbl, 6 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
CONTRACEPTIVE INJECTION OF OIL SOLUTION INJECTED INDEPENDENTLY | 2003 |
|
RU2328289C2 |
USING 3-ANDROSTANEDIOL OPTIONALLY IN COMBINATION WITH 5-HT1A ANTAGONIST FOR TREATING SEXUAL DYSFUNCTION | 2007 |
|
RU2491073C2 |
DOUBLE NEUROKININ-1/NEUROKININ-3 RECEPTOR ANTAGONISTS FOR TREATING SEX HORMONE DEPENDENT DISEASES | 2016 |
|
RU2743206C2 |
USE OF NOVEL ETHONOGESTREL ESTERS | 2003 |
|
RU2322986C2 |
METHOD OF TREATING MALE INFERTILITY | 2020 |
|
RU2738543C2 |
BIRTH CONTROL TECHNIQUE USED AS AND WHEN NECESSARY | 2010 |
|
RU2542779C2 |
COMPOSITIONS AND METHOD FOR RELIEVING RESPIRATORY DISTRESS CAUSED BY OPIOID OVERDOSE | 2011 |
|
RU2541159C2 |
PHARMACEUTICAL COMPOSITION, CONTAINING OPIOID ANTAGONIST FOR TREATMENT OF URINARY RETENTION | 2009 |
|
RU2478388C2 |
COMPOUND (α)-7-METHYL-17-[(1-OXOUNDECYL)OXY]-ESTR-4-ENE-3-ONE, PHARMACEUTICAL COMPOSITION, SET FOR MALE CONTRACEPTION | 1999 |
|
RU2216546C2 |
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASES | 2018 |
|
RU2715419C1 |
Authors
Dates
2023-07-11—Published
2019-03-22—Filed